Fujian announces the third batch of medical insurance key monitoring drugs and the list of key drugs

On February 8, 2022, the Fujian Provincial Joint Purchasing Center for Pharmaceuticals and Equipment issued the "Notice on the Announcement of the Third Batch of Medical Insurance Key Monitoring Drugs and the List of Key Drugs"
.
The notice shows that in accordance with the spirit of the document "Notice of Fujian Provincial Medical Insurance Bureau on Strengthening the Management of Drugs under Medical Insurance Key Monitoring" (Min Medical Insurance [2019] No.
24), with the approval of the Provincial Medical Insurance Bureau, the "Third Batch of Medical Insurance Key Monitoring Drugs List" and the "Third Batch of Medical Insurance Focused Drug List" to be announced
.
The drugs that originally belonged to the second batch of key monitoring and key monitoring lists, except those that were included in the third batch of key monitoring and key monitoring lists, are no longer subject to key monitoring and key monitoring
.